Mortality in Children Treated With Maintenance Peritoneal Dialysis: Findings From the International Pediatric

Sophie Ploos van Amstel1, Marlies Noordzij1, Dagmara Borzych-Duzalka2

  • 1IPNA Global RRT Registry, Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.

Insights

Pediatric maintenance peritoneal dialysis (MPD) shows high survival rates globally. However, mortality risk in children on MPD is linked to country income, with lower-income nations experiencing higher rates.

Area of Science:

  • Pediatric Nephrology
  • Global Health
  • Renal Replacement Therapy

Background:

  • Kidney replacement therapy (KRT) research in children is concentrated in Europe and North America.
  • Limited data exists on pediatric maintenance peritoneal dialysis (MPD) outcomes worldwide.
  • Understanding global disparities in pediatric MPD is crucial for equitable care.

Purpose of the Study:

  • To assess the mortality risk of children undergoing maintenance peritoneal dialysis (MPD) across diverse global regions.
  • To identify demographic, clinical, and macroeconomic factors associated with pediatric MPD mortality.
  • To investigate the influence of country income on survival rates in pediatric MPD patients.

Main Methods:

  • Prospective cohort study involving 2,956 children initiating MPD between 1996 and 2017.
  • Analysis of all-cause MPD mortality over a 3-year observation period.
  • Statistical modeling to determine factors influencing mortality variation, including region and income level.

Main Results:

  • Overall 3-year survival probability on pediatric MPD was high (95%).
  • Mortality rates varied significantly by region, from 2% in North America to 9% in Eastern Europe.
  • Lower-income countries exhibited higher MPD mortality rates compared to high-income countries, with income category explaining over 50% of regional variance.

Conclusions:

  • Pediatric MPD demonstrates favorable 3-year survival rates globally.
  • Country income level is a significant determinant of patient survival in pediatric MPD.
  • Addressing socioeconomic factors is essential to reduce interregional disparities in pediatric KRT outcomes.
Abstract

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
220
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
330
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
899
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
105
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
102